Minority resistant variants are also present in HIV-2-infected antiretroviral-naive patients.
Storto A, Visseaux B, Bertine M, Le Hingrat Q, Collin G, Damond F, Khuong MA, Blum L, Tubiana R, Karmochkine M, Cazanave C, Matheron S, Descamps D, Charpentier C; ANRS HIV-2 CO5 Cohort.
Storto A, et al. Among authors: blum l.
J Antimicrob Chemother. 2018 May 1;73(5):1173-1176. doi: 10.1093/jac/dkx530.
J Antimicrob Chemother. 2018.
PMID: 29415189